Macromill Carenet, Inc.
| Booth No. | 2-251 |
|---|
|
Extensive Track Record in Unexplained Medical Symptoms (UMS): Driving Clinical Trial Success with Rich Expertise and Strategic Protocol Design
We are a specialized CRO with an extensive track record in clinical trials for Unexplained Medical Symptoms (UMS). Even for complex topics where subjective efficacy is difficult to evaluate, we leverage our proven expertise and strategic protocol design to build high-precision study architectures.
Combining target screening capabilities powered by our large-scale panel with robust trial execution, we empower clients to develop novel health claims and acquire reliable evidence for Foods with Function Claims (FFC).
|
| Product / Service |
Clinical Trial Services |
|---|---|
| URL | https://www.macromillcarenet.jp/english/ |
Presentaion
| Date | 11:00 11:05～ | Location | PC |
|---|---|---|---|
| Title | Why Is It Difficult to Evaluate Emotional Value? Approaching Objective Assessment of Emotions Through Facial Expression Analysis and Other Cutting-Edge Technologies! | ||
| Detail | Why is objective evaluation of human emotions so challenging? This presentation delves into state-of-the-art evaluation models that utilize facial expression analysis, speech analysis, and biological responses. By combining subjective evaluation (surveys) with objective data (biological markers), researchers can uncover nuanced product effects and meanings that words alone cannot capture. Join us to discover cutting-edge evaluation technologies that drive product differentiation and elevate market value. | ||
| Date | 11:00 11:05～ | Location | PD |
|---|---|---|---|
| Title | Evaluation method for work engagement improvement foods through biosignal analysis | ||
| Detail | Today’s office workers increasingly demand food products that foster "work engagement"—a state of being relaxed, yet mentally sharp and focused. In this presentation, we will explain the brain mechanisms that maintain alertness while boosting alpha waves and suppressing excessive excitement (noise). Furthermore, we will introduce methodologies to accurately measure and evaluate these mental states using biological signal analysis. | ||
| Date | 12:00 12:05～ | Location | PH |
|---|---|---|---|
| Title | The key to femcare trials lies in home evaluation! Trial design evolving through device utilization | ||
| Detail | In clinical trials for Femcare food products, the key to success lies in "at-home evaluation"—capturing symptoms that fluctuate on a daily basis. This presentation explores cutting-edge evaluation methodologies utilizing digital devices, alongside optimal PMS subject stratification tailored to specific active ingredients. Discover the complete picture of next-generation study designs that minimize subject burden while acquiring high-precision evidence. | ||
| Date | 13:00 13:05～ | Location | PH |
|---|---|---|---|
| Title | Must-see for material developers! Evolution of evaluation technology based on material characteristics - PMS testing as a case study | ||
| Detail | The Femcare and Homme-care (men’s care) sectors are expanding rapidly in the functional health market. Using PMS (Premenstrual Syndrome) clinical trials as a case study, this presentation explores the cutting edge of evaluation technologies designed to maximize the potential of your raw materials. We will share essential, up-to-date insights for ingredient developers, including clever subject classification and study designs tailored to specific active components. Join us to discover practical expertise that will shape the future of functional food development. | ||
| Date | 13:30 13:35～ | Location | PH |
|---|---|---|---|
| Title | The Hottest Topic Right Now: Women's Menopause Trials! Expert Tips on Avoiding Common Pitfalls Before Implementation | ||
| Detail | Planning a clinical trial in the menopausal health domain? Menopause studies present unique challenges, such as over-reliance on total SMI (Simplified Menopause Index) scores and high placebo response rates. In this session, we will explain how to implement proper subject screening and study design by accounting for daily symptom fluctuations and the prevalence of physical, psychological, and vasomotor symptoms. Discover actionable expertise to ensure the success of your product development. | ||
| Date | 14:00 14:05～ | Location | PM |
|---|---|---|---|
| Title | Learn from the 'Working Group's Perspective on Clinical Trial Standards'! Professor Yohei Kawasaki of Saitama Medical University Graduate School Provides a Thorough Explanation of the Statistical Analysis Required for Foods with Function Claims! | ||
| Detail | We are pleased to welcome Professor Yohei Kawasaki from Saitama Medical University, a member of the "Working Group on the Methodology of Clinical Trials for Foods with Function Claims." He will provide a comprehensive overview of statistical analysis in Foods with Function Claims (FFC), covering everything from fundamental concepts to practical applications. This seminar is a must-attend not only for clinical trial specialists interested in FFC, but also for professionals involved in regulatory filings, pharmaceutical affairs, and quality assurance. | ||
| Date | 14:30 14:35～ | Location | PH |
|---|---|---|---|
| Title | Turning Ingredient Strengths into Consumer Value! A Process Guide to Discovering New Health Claims | ||
| Detail | Struggling to communicate the true potential of your functional ingredients? In today’s saturated functional food market, success requires more than just clinical data—it demands translating evidence into "relatable, real-world value" for consumers. Based on our consulting track record with over 20 companies, this session provides a clear, step-by-step process for unlocking the full appeal of your raw materials and crafting compelling narratives that move the market. | ||
| Date | 15:00 15:05～ | Location | PB |
|---|---|---|---|
| Title | The key to femcare trials lies in home evaluation! Trial design evolving through device utilization | ||
| Detail | In clinical trials for Femcare food products, the key to success lies in "at-home evaluation"—capturing symptoms that fluctuate on a daily basis. This presentation explores cutting-edge evaluation methodologies utilizing digital devices, alongside optimal PMS subject stratification tailored to specific active ingredients. Discover the complete picture of next-generation study designs that minimize subject burden while acquiring high-precision evidence. | ||
| Date | 15:30 15:35～ | Location | PB |
|---|---|---|---|
| Title | Multimodal analysis of EEG × heart rate variability reveals the ”true experience” of food | ||
| Detail | "No significant difference compared to placebo in subjective evaluations..." This common hurdle occurs because mild product effects get buried under the noise of mood and placebo effects. In this presentation, we explain "multimodal analysis," which simultaneously measures both the central nervous system (such as alpha waves) and the peripheral nervous system (heart rate variability). We will introduce evaluation technologies that objectively capture biological responses and visualize the "true subjective experience" delivered by functional foods. | ||
| Date | 16:00 16:05～ | Location | PH |
|---|---|---|---|
| Title | Expert Tips on Avoiding Common Pitfalls in Subjective Evaluation of Clinical Trials — Know-How from a Research Company | ||
| Detail | Struggling with high variability in subjective evaluation data and a lack of statistically significant differences? Improving the precision of subjective measures is essential in clinical trials for Foods with Function Claims (FFC). Using PMS evaluation as a case study, this session thoroughly explores the factors that influence subjective outcomes. We will share actionable expertise that researchers can implement immediately to ensure trial success, including strategies to prevent memory bias and analysis designs that account for covariates. | ||
| Date | 16:30 16:35～ | Location | PH |
|---|---|---|---|
| Title | After women’s menopause comes men’s menopause! Trial design considering the actual situation of concern | ||
| Detail | Male menopause (Late-Onset Hypogonadism / LOH) is rapidly emerging as the next major growth area following female menopausal care. Based on a comprehensive study of 5,000 men, this presentation reveals data on the "unaware potential population" and breaks down physical, psychological, and sexual symptoms. Aligned with the latest clinical guidelines, we share practical trial design expertise—from target screening to outcome measure selection—directly applicable to developing Foods with Function Claims (FFC). | ||